These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26443632)

  • 1. A developmental framework for induced pluripotency.
    Takahashi K; Yamanaka S
    Development; 2015 Oct; 142(19):3274-85. PubMed ID: 26443632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of somatic cell reprogramming.
    Wang Y; Bi Y; Gao S
    Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: harmonies played by microRNAs in cell fate reprogramming.
    Moradi S; Asgari S; Baharvand H
    Stem Cells; 2014 Jan; 32(1):3-15. PubMed ID: 24155164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and artificial routes to pluripotency.
    Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
    Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in embryonic stem cell and induced pluripotent stem cell differentiation in male germ cells.
    Mahabadi JA; Sabzalipoor H; Nikzad H; Seyedhosseini E; Enderami SE; Gheibi Hayat SM; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12278-12289. PubMed ID: 30536380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular reprogramming to reset epigenetic signatures.
    Hewitt KJ; Garlick JA
    Mol Aspects Med; 2013; 34(4):841-8. PubMed ID: 22982217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the formation of induced pluripotent stem cells.
    González F; Huangfu D
    Wiley Interdiscip Rev Dev Biol; 2016; 5(1):39-65. PubMed ID: 26383234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
    Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
    Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hierarchy in reprogramming capacity in different tissue microenvironments: what we know and what we need to know.
    Liebau S; Mahaddalkar PU; Kestler HA; Illing A; Seufferlein T; Kleger A
    Stem Cells Dev; 2013 Mar; 22(5):695-706. PubMed ID: 23167697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor.
    Matsuda Y; Semi K; Yamada Y
    Pathol Int; 2014 Jul; 64(7):299-308. PubMed ID: 25047500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular framework underlying pluripotency.
    Loh YH; Ng JH; Ng HH
    Cell Cycle; 2008 Apr; 7(7):885-91. PubMed ID: 18414030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
    Benevento M; Munoz J
    Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: the dynamics of induced pluripotency and its behavior captured in gene network motifs.
    Muraro MJ; Kempe H; Verschure PJ
    Stem Cells; 2013 May; 31(5):838-48. PubMed ID: 23362218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.